Time Medical International Ventures (India) Pvt. Ltd., a wholly owned subsidiary of Fischer Medical Ventures Limited, has announced the appointment of Dr. Iype Cherian, globally acclaimed neurosurgeon, educator, and innovator, as Director of Fischer Medical Ventures Limited. Under his leadership, the company is spearheading the development of a revolutionary intraoperative MRI technology — DRIS–iMRI Medharanya, an advanced, AI-enabled, portable MRI system designed to transform neurosurgical imaging and practice.
With his invaluable expertise and visionary inputs, the company is confident that Dr. Cherian’s presence will drive a new wave of innovation and development, strengthening Fischer Medical’s commitment to advancing next-generation imaging technologies and neurosurgical solutions. The Interop MRI is designed to revolutionize intraoperative imaging, providing surgeons with real-time visualization during complex neurosurgical procedures. This innovation enables unprecedented precision, safety, and control in surgeries that traditionally rely on limited visual feedback.
DRIS–iMRI Medharanya represents a next- generation, AI-enabled, portable MRI system that integrates Augmented Reality (AR), Artificial Intelligence and Machine Learning (AI/ML), and Exoscope technologies. Designed to transform neurosurgical and neurodiagnostic practice, it enables unparalleled precision, visualization, and accessibility in real-time intraoperative imaging. Clinically, DRIS–iMRI Medharanya also embodies the Extradural Parasigmoid approach to the Jugular Foramen (Ex Pa JuF) — a groundbreaking surgical pathway for managing complex glomus tumours with enhanced safety and anatomical clarity.
Dr. Iype Cherian is a pioneering neurosurgeon, educator, and innovator whose distinguished career embodies surgical mastery, inventive spirit, and global impact. Having completed his M.Ch (Neurosurgery) at CMC, Vellore, and a Fellowship in Skull Base and Vascular Neurosurgery at Nagoya, Dr. Cherian has devoted his life to advancing the frontiers of neurosurgical science and education.
His groundbreaking contributions include the description of Craniotomy (2007) and the concept of Brain Cooling, both of which have significantly influenced contemporary neurosurgical practice and postoperative recovery strategies. Renowned for “Unlocking the Skull Base,” he developed and refined advanced microsurgical routes such as the Transcavernous and Modified Kawase approaches—creating safer and more effective pathways to access complex intracranial regions. As General Counsellor of the Asian Congress of Neurological Surgeons (ACNS, 2021), Dr. Cherian is widely recognized as a global authority in Ultra Micro Neurosurgery and in the design of next-generation surgical instruments. His visionary approach led to the creation of the world’s first Exoscope – Sanma Yoko, with which he has amassed one of the largest global experiences in Exoscope Surgery. His inventive portfolio extends to the STMC Bypass Set, the Medharanya Theatre Concept, the Sookshmaranga Endovascular Robot, and DRIS–iMRI, all reflecting his deep commitment to precision, technological innovation, and patient-centered excellence. Currently serving as Director of Neuro Sciences at the Parul Institute of Medical Sciences & Research, he continues to mentor surgeons worldwide as the Founder and President of Neurosurgery Coach, his global training initiative promoting advanced micro-neurosurgical skill development. He is also the Counsellor General of the Asian Congress of Neurological Surgeons (ACNS).
His initiative, Neurosurgery Coach, stands as a premier platform for nurturing young neurosurgeons across the world, imparting critical micro-neurosurgical techniques and strategic surgical thinking. A true visionary in accessible healthcare, Dr. Cherian remains deeply mindful that the majority of the world’s population resides in low- and middle-income countries where advanced neurosurgical infrastructure is limited. His mission is to empower surgeons from these regions to lead the next era of neurosurgical excellence—rooted in compassion, innovation, and purpose.
Dr. Iype Cherian, Neurosurgeon at Parul University, explained:
“Glioma surgery is generally a blind surgery. Interoperative MRI gives vision to the surgeon — allowing them to see what has been taken and what is left. Small intraparenchymal lesions would be much easier to remove definitively if live imaging were available intraoperatively.”
Ms. Svetlana, Director, Time Medical International Ventures (I) P Ltd:
‘With Dr. Cherian’s expertise and vision, Time Medical is entering an exciting new phase of innovation. The Interop MRI represents our commitment to developing cutting-edge, accessible solutions that bring world-class imaging into the surgical environment.”